Chimerix (CMRX) Reports In-Line Q1 EPS, Announces Strategy Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Chimerix Announces First Quarter 2019 Financial Results and Strategy Update
May 9, 2019 8:00 AM EDTReports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission
Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir Development Activities
Restructuring to Reduce Workforce by More Than 50%, Maintaining Key Capabilities and Preserving Capital for New Programs
Conference Call at 8:30 a.m. ET Today
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), today reported financial results for the first quarter ended March 31, 2019 and provided an update on... More
